Evidence map›Paper›PMID 28475773›Full record

ReviewEuropean heart journal2017

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.

Felix Mahfoud, Roland E Schmieder, Michel Azizi, Atul Pathak, Horst Sievert, Costas Tsioufis, Thomas Zeller, Stefan Bertog, Peter J Blankestijn, Michael Böhm and 19 more

Erratum issued 2 registry-linked trialsAbstract readReviewConsensus Statement
In one paragraph

Review in European heart journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 49 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04264403 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2020 to 2024Enrolled44ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease stage3ArmsRenal denervation
NCT07742787 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorHippocration General HospitalRan2024 to 2027Enrolled20ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease (Stage 3)ArmsRenal denervation, Sham procedure control
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Systematic review of renal denervation for the management of cardiac arrhythmias.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Pooled it
  4. Pooled it
  5. Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2018
    Pooled it
  6. Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Trial
  7. Prioritised endpoints for device-based hypertension trials: the win ratio methodology.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2021
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Renal denervation for hypertension.Nature reviews. Cardiology · 2025
    Review
  15. Review
  16. Article
  17. Device's design and clinical perspectives for resistant hypertension therapy.International journal of cardiology. Cardiovascular risk and prevention · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Felix MahfoudKlinik für Innere Medizin III, Saarland University Hospital, Angiologie und Internistische Intensivmedizin, 66421 Homburg, Saar, Germany.
Roland E SchmiederDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.
Michel AziziParis-Descartes University, Paris, France.
Atul PathakDepartment of Cardiovascular Medicine, Hypertension, Risk Factors and Heart Failure Unit, Clinique Pasteur, Avenue de Lombez, Toulouse, France.
Horst SievertCardioVascular Center (CVC), Seckbacher Landstraße, Frankfurt, Germany.
Costas Tsioufis1st Department of Cardiology, National and Kapodistrian University of Athens, Greece.
Thomas ZellerKlinik Kardiologie und Angiologie II, Universitaets-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany.
Stefan BertogCardioVascular Center (CVC), Seckbacher Landstraße, Frankfurt, Germany.
Peter J BlankestijnDepartment of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
Michael BöhmKlinik für Innere Medizin III, Saarland University Hospital, Angiologie und Internistische Intensivmedizin, 66421 Homburg, Saar, Germany.
Michel BurnierService of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland.
Gilles ChatellierUniversité Paris-Descartes, F-75006 Paris, France.
Isabelle Durand ZaleskiECEVE, UMR 1123, AP HP URCEco Ile de France Hopital de l'Hotel Dieu, Paris, France.
Sebastian EwenKlinik für Innere Medizin III, Saarland University Hospital, Angiologie und Internistische Intensivmedizin, 66421 Homburg, Saar, Germany.
Guido GrassiClinica Medica, Università Milano-Bicocca, Italy.
Michael JonerDeutsches Herzzentrum München, Klinik für Kardiologie, Germany.
Sverre E KjeldsenECEVE, UMR 1123, AP HP URCEco Ile de France Hopital de l'Hotel Dieu, Paris, France.
Melvin D LoboWilliam Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK.
Chaim LotanClinica Medica, Università Milano-Bicocca, Italy.
Thomas Felix LüscherIRCCS Multimedica, Sesto San Giovanni, Milan, Italy.
Gianfranco ParatiDeutsches Herzzentrum München, Klinik für Kardiologie, Germany.
Patrick RossignolINSERM, Centre d'Investigations Cliniques Plurithématique 1433 & U1116, Université de Lorraine, CHRU de Nancy, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Luis RuilopeInstitute of Investigation imas12 and Hypertension Unit, Hospital 12 de Octubre; Department of Preventive Medicine and Public Health, Universidad Autonoma and Department of Postdoctoral Studies and Investigation, Universidad Europea de Madrid, Madrid, Spain.
Faisal SharifCURAM, Cardiovascular Research Centre (CVRC) and BioInnovate Ireland, National University of Ireland Galway, Ireland.
Evert van LeeuwenDepartment IQ healthcare, section Ethics, Radboudumc, Nijmegen, The Netherlands.
Massimo VolpeCardiology, Department of Clinical and Molecular Medicine, University of Rome Sapienza, Rome and IRCCS Neuromed, Pozzilli, Italy.
Stephan WindeckerDepartment of Cardiology, Bern University Hospital, Bern, Switzerland.
Adam WitkowskiDepartment of Interventional Cardiology & Angiology, Institute of Cardiology, Warsaw, Poland.
William WijnsThe Lambe Institute for Translational Medicine and Curam, National University of Ireland, Galway, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Societies, MedicalBlood PressureCatheter AblationCongresses as TopicEquipment DesignEuropeHumansHypertensionKidneyPractice Guidelines as TopicSympathectomy

Identifiers

PMID28475773
PMCPMC5837218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.